US Patent 11234976 Methods of using pyruvate kinase activators
Patent 11234976 was granted and assigned to Agios Pharmaceuticals on February, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11234976 Methods of using pyruvate kinase activators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.